Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-26T21:55:01.363Z Has data issue: false hasContentIssue false
  • English
  • Français

Laryngeal carcinoma: five-year survival and patterns of failure in 202 consecutive patients treated with primary or post-operative radiotherapy in Hong Kong

Published online by Cambridge University Press:  26 January 2006

Alexander C Vlantis ,
Brian K H Yu ,
Raymond K Y Tsang ,
Michael K M Kam ,
Phoebe S Y Lo  and
C Andrew van Hasselt
Alexander C Vlantis
Affiliation:
Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China
Brian K H Yu
Affiliation:
Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China
Raymond K Y Tsang
Affiliation:
Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China
Michael K M Kam
Affiliation:
Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China
Phoebe S Y Lo
Affiliation:
Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China
C Andrew van Hasselt
Affiliation:
Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives: We aimed to conduct a retrospective analysis of patients treated with radiotherapy for laryngeal carcinoma at a single institution.

Methods: We analysed data from 202 consecutive patients treated with primary or post-operative radiotherapy for laryngeal carcinoma over a 10-year period.

Results: Sixty-nine patients had a T1, 65 a T2, 39 a T3 and 29 a T4 lesion. Forty-one patients were node-positive. The clinical stage was I in 67 patients, II in 53, III in 36 and IV in 46. Primary radiotherapy was given to 152 patients. The median follow up was 60 months. The five-year overall local control rate was 86 per cent, the ultimate local control rate was 93 per cent, the five-year regional control rate was 96 per cent, the five-year relapse-free survival rate was 82 per cent and the five-year overall survival rate was 69 per cent.

Conclusions: Patients with laryngeal carcinoma treated with primary or post-operative radiotherapy had a five-year overall survival rate of 69 per cent.

Keywords

LarynxCarcinomaRadiotherapySurvival
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 120 , Issue 5 , May 2006 , pp. 397 - 404
Copyright
© 2006 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)